Inventor
EBEL HEINER
DE18 patents
⚠️ This page may combine multiple inventors who share the name “EBEL HEINER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EBEL HEINER
10 patentsUS9067951B2Jun 30, 2015
Process and intermediates for the production of CCR2 antagonists
EBEL HEINER20 citations91
US8962656B2Feb 24, 2015
CCR2 antagonists
EBEL HEINER9 citations83
US8841313B2Sep 23, 2014
CCR2 antagonists and uses thereof
EBEL HEINER9 citations83
US8765949B2Jul 1, 2014
CCR2 receptor antagonists and uses thereof
EBEL HEINER9 citations83
US8835440B2Sep 16, 2014
Cyclic pyrimidin-4-carboxamides as CCR2 receptor antagonists for treatment of inflammation, asthma and COPD
EBEL HEINER9 citations82
US9108958B2Aug 18, 2015
Selective CCR2 antagonists
EBEL HEINER4 citations72
US8877745B2Nov 4, 2014
CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
EBEL HEINER2 citations51
US9018212B2Apr 28, 2015
Pyridazine carboxamides as CCR2 receptor antagonists
EBEL HEINER0 citations41
US8946218B2Feb 3, 2015
CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
EBEL HEINER0 citations41
US8653262B2Feb 18, 2014
CCR2 receptor antagonists and uses thereof
EBEL HEINER0 citations38
CENTREXION THERAPEUTICS CORP
5 patentsUS11046706B2Jun 29, 2021
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP3 citations83
US10196402B2Feb 5, 2019
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP7 citations83
US9670222B2Jun 6, 2017
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP9 citations83
US11731981B2Aug 22, 2023
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP1 citations72
US12209094B2Jan 28, 2025
CCR2 receptor antagonists and uses thereof
CENTREXION THERAPEUTICS CORP0 citations62